About Us | Executive Team | Barri M. Blauvelt

Barri M. Blauvelt

Barri M. Blauvelt
CEO & President
Innovara, Inc.
Barri Blauvelt founded Innovara, Inc., a global business and management development firm dedicated to providing highly customized, results-oriented services to health care, financial services, insurance, and other industries worldwide. Mrs. Blauvelt services clients mainly in the areas of basic and advanced sales and marketing management training and development, market and business potential analysis, benchmarking best practices, medical education, and business and marketing strategy consulting.
Prior to forming Innovara, Inc., Mrs. Blauvelt had twelve years of marketing, sales and management experience in major corporations. She began her career in international patent and trademark law with Pennie and Edmonds and in Public Affairs with Exxon Corporation, both in New York City. Raised internationally and in the USA, she has held sales and marketing management positions with Pfizer in the USA and positions as Far East Area Manager of Medical Products (Lederle and Davis & Geck Divisions), Marketing Manager of Latin America/Canada/Far East Division, and Global Head of Marketing and Sales, for Lederle Laboratories in charge of both ethical and consumer health care products, for American Cyanamid Company. While at Cyanamid, she also was the head of the Licensing and Trademarks Committee for the company and Chairman of the Asia Subcommittee of the Pharmaceutical Manufacturers’ Association (Washington DC) and US/China Trade Commission (in cooperation with US and PRC governments).
Mrs. Blauvelt has a BA degree in international education and pre-law. She holds an MBA in marketing from the Graduate School of Business, Columbia University in New York City, where she also studied Law (LLB) and Management Sciences (PhD). She also serves as a guest instructor at several leading Graduate Schools of Business, Medicine and Public Health in the USA and as a guest lecturer at major universities around the world.
Mrs. Blauvelt is a published author of articles on benchmarking best practices and on marketing management. In addition, she is active in a number of professional associations in the United States and overseas, including ASTD where she was VP Marketing (local chapter). She is frequently invited to speak at industry and government congresses both in the United States and overseas.
Full Name:  Barri M. Blauvelt
Job Title:  Chief Executive Officer and President
Company:  Innovara, Inc.
Business Address:  105 Middle Street
 Hadley, MA 01035
Business:  (413) 387-6188
Business Fax:  (413) 387-6772
E-mail:   This e-mail address is being protected from spambots. You need JavaScript enabled to view it

CEO & President
Innovara, Inc.

Adjunct Faculty, Institute for Global Health
University of Massachusetts

Contact

Barri Blauvelt is Adjunct Faculty, Institute for Global Health, at the University of Massachusetts and also is CEO of Innovara, Inc. a global health care consultancy company.  Her role at the IGH is mainly conducting qualitative studies involving medical, policy and advocacy developments globally. 

In 2009, she was invited to join the US President’s Cancer Panel.  In October, 2009, she presented and submitted a white paper to the Panel on “Ethnicity of Cancer: Global Learnings and Implications for US policy” (now archived by the NIH).   In March/April 2010, she helped facilitate and then develop the final consensus publication and recommendations, Improving Cancer Care in the Arab World presented at the Pan-Arab Conference 2010 (Algiers) and and adopted by the WHO in May (www.ICCAW.org).  In July, 2010, she presented on “The Future Epidemic: Obesity, Diabetes and Cancer” at U. of Massachusetts, and with coauthors from USA, EU, Latin America and Asia, is preparing for publication in 2011. 

Some studies she is currently conducting or has conducted in collaboration with colleagues at U. of Massachusetts as well as other leading schools of public health and medicine (Johns Hopkins, Cleveland Clinic, Massachusetts General Hospital, Brigham & Women’s Hospital, MD Anderson Cancer Center, University of Virginia, et al) have mainly involved cancer, diabetes, cardiovascular disease, infectious disease, endocrinology, rheumatology, ophthalmology, and pulmonology.

In addition, she is the author of Powerful Medical Presenter, a medical presentation skills curriculum developed for Harvard faculty at Massachusetts General Hospital, and is co-author of  From Clinical Research to Publication and co-instructed with leading faculty from Johns Hopkins University Medical Institutes.

She also is Chair of Women in High Places, the exclusive network of the 200 highest ranking women in health care medicine, policy, advocacy and industry in the world, with particular focus on cancer and diabetes.

Raised and educated internationally (Asia, Canada, Europe, US),  Mrs. Blauvelt worked in international patent and trademark law with a leading global intellectual property firm out of New York City, and held managerial positions with Exxon Corporation,  Pfizer and American Cyanamid, eventually rising to become responsible for Asian and then global commercialization of Lederle and Davis & Geck Divisions.  She has held positions as Chair of the US/China Trade Commission (in cooperation with US and PRC governments). She also founded and leads Innovara, Inc. a leading company in global medical thought leadership development.

Mrs. Blauvelt has a BA degree in international education and pre-law from Hampshire College.  She holds an MBA from the Graduate School of Business, Columbia University in New York City, where she also studied law and post-doctoral level Management Sciences. 


Full Name: Barri M. Blauvelt
Job Title: Chief Executive Officer and President
Company: Innovara, Inc.
Business Address: 105 Middle Street
Hadley, MA 01035
Business: (413) 387-6188
Business Fax: (413) 387-6772
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it